Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase

被引:65
|
作者
Hamstra, DA
Rice, DJ
Fahmy, S
Ross, BD
Rehemtulla, A
机构
[1] Univ Michigan, Sch Med, Dept Radiat Oncol, Med Ctr, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Med Ctr, Dept Pharmacol, Ann Arbor, MI 48105 USA
[3] Univ Michigan, Med Ctr, Dept Radiol, Ann Arbor, MI 48105 USA
[4] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48105 USA
关键词
D O I
10.1089/10430349950017356
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of cytosine deaminase (CD) in conjunction with 5-fluorocytosine (5-FC) has been studied for cancer gene therapy as a means of achieving tumor-specific generation of the toxic metabolite 5-fluorouracil (5-FU), Since 5-FC is frequently used as an antifungal agent, and because it has little or no efficacy as an antibacterial agent, we hypothesized that yeast CD (YCD) might be more efficient at utilizing 5-FC as a substrate and hence be a better choice for a CD/5-FC gene therapy strategy than the typically utilized bacterial CD (BCD), To that end Saccharomyces cerevisiae CD was cloned from yeast genomic DNA and expressed in vitro. Functional analysis of BCD and YCD expressed in COS-1 cells indicated that BCD and YCD both utilized cytosine with equal efficacy; however, 5-FC was an extremely poor substrate for BCD, with an apparent catalytic efficiency 280-fold lower than that observed for YCD, Retroviral infection of tumor cell lines in vitro indicated that the IC50 of 5-FC was 30-fold lower in PCD-infected cultures as compared with cultures infected with BCD retrovirus, In addition, when SCCVII murine squamous cell carcinoma cells were infected in vitro at low rates of infection (less than or equal to 10%) there was no significant cytotoxicity toward BCD-expressing cells while there was potent cytotoxicity to both YCD-expressing cells and "bystander cells" even at this low level of expression. Finally, stable BCD- or YCD-expressing SCCVII clones were developed and used in an orthotopic immune-competent model of head and neck cancer. Subsequent treatment with 5-FC followed by monitoring of tumor growth by noninvasive magnetic resonance imaging (MRI) and survival of animals indicated a growth delay during the course of 5-FC treatment for BCD-expressing tumors, which quickly regrew at the end of treatment. In contrast, YCD-expressing tumors exhibited not only a growth delay, which was of longer duration, but also in some cases frank tumor regression and complete cures occurred.
引用
收藏
页码:1993 / 2003
页数:11
相关论文
共 50 条
  • [41] Non-viral Suicide Gene Therapy: Cytosine Deaminase Gene Directed by VEGF Promoter and 5-fluorocytosine as a Gene Directed Enzyme/prodrug System in Breast Cancer Model
    Emamian, Manouchehr
    Abbaspour, Akbar
    Shahani, Tina
    Biglari, Alireza
    Sharafi, Ali
    DRUG RESEARCH, 2021, 71 (07) : 395 - 406
  • [42] Hypoxia-induced cytosine deaminase gene expression for cancer therapy
    Lee, Che-Hsin
    Wu, Chao-Liang
    Shiau, Ai-Li
    HUMAN GENE THERAPY, 2007, 18 (01) : 27 - 38
  • [43] Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer
    Rowley, S
    Lindauer, M
    Gebert, JF
    Haberkorn, U
    Oberdorfer, F
    Moebius, U
    Herfarth, C
    Schackert, HK
    JOURNAL OF SURGICAL ONCOLOGY, 1996, 61 (01) : 42 - 48
  • [44] Image-guided enzyme/prodrug cancer therapy
    Li, Cong
    Penet, Marie-France
    Winnard, Paul, Jr.
    Artemov, Dmitri
    Bhujwalla, Zaver M.
    CLINICAL CANCER RESEARCH, 2008, 14 (02) : 515 - 522
  • [45] Gene therapy for head and neck cancer
    Gleich, LL
    LARYNGOSCOPE, 2000, 110 (05): : 708 - 726
  • [46] DNA therapy for head and neck cancer
    Mandy Aujla
    Nature Reviews Clinical Oncology, 2009, 6 (6) : 302 - 302
  • [47] COMBINATION THERAPY IN HEAD AND NECK CANCER
    ARON, BS
    LORVIDHAYA, V
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 233 (02): : 177 - 178
  • [48] Radiation therapy in head and neck cancer
    Alfouzan, Afnan F.
    SAUDI MEDICAL JOURNAL, 2021, 42 (03) : 247 - 254
  • [49] Gene Therapy in Head and Neck Cancer
    Farmer, Zachary L.
    Kim, Edward S.
    Carrizosa, Daniel R.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2019, 31 (01) : 117 - +
  • [50] Photodynamic therapy of head and neck cancer
    Kübler, AC
    Scheer, M
    Zöller, JE
    ONKOLOGIE, 2001, 24 (03): : 230 - 237